Drug Development Digital Twins for Drug Discovery, Testing and Repurposing: A Schema for Requirements and Development

49Citations
Citations of this article
68Readers
Mendeley users who have this article in their library.

Abstract

There has been a great deal of interest in the concept, development and implementation of medical digital twins. This interest has led to wide ranging perceptions of what constitutes a medical digital twin. This Perspectives article will provide 1) a description of fundamental features of industrial digital twins, the source of the digital twin concept, 2) aspects of biology that challenge the implementation of medical digital twins, 3) a schematic program of how a specific medical digital twin project could be defined, and 4) an example description within that schematic program for a specific type of medical digital twin intended for drug discovery, testing and repurposing, the Drug Development Digital Twin (DDDT).

Cite

CITATION STYLE

APA

An, G., & Cockrell, C. (2022). Drug Development Digital Twins for Drug Discovery, Testing and Repurposing: A Schema for Requirements and Development. Frontiers in Systems Biology, 2. https://doi.org/10.3389/fsysb.2022.928387

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free